{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T04:22:18Z","timestamp":1748146938469,"version":"3.40.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>The new vaccines are emergently authorized and currently approved for use to protect against the coronavirus disease 2019 (COVID-19) pandemic and serious adverse events are uncommon. Moyamoya disease (MMD) with autoimmune disease is a rare entity and usually presents with intracranial hemorrhage in adults.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We reported a 40-year-old female patient with Sjogren disease and autoimmune thyroiditis, who had received the second dose of Moderna (mRNA-1273) vaccination. Three days later, she presented with left intraventricular and intracerebral hemorrhage as a complication.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>After a series of diagnostic workups, left intracranial hemorrhage was associated with MMD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Emergent external ventricular drainage and subsequent stereotactic evacuation of hematoma with insertion of intracranial pressure monitoring were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Under the care of the neurocritical care team, her physical condition improved gradually. The neurological sequelae was noted by defects of cognitive function, apraxia, agnosia, and impaired executive function. She was discharged after eight weeks with a follow-up in the vascular neurology clinic planning for performing revascularization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>To the best of our knowledge, no similar case has been reported before, and this is the first case of MMD complicated with intracerebral and intraventricular hemorrhage after mRNA-1273 vaccination. It is noticeable to assess the vaccine safety surveillance and raise the alertness about moyamoya in patients with autoimmune diseases during the COVID-19 pandemic. Further studies for risk evaluation of COVID-19 vaccines in patients with autoimmune diseases might be required in the future.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028756","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T13:03:20Z","timestamp":1644584600000},"page":"e28756","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Moyamoya disease with Sjogren disease and autoimmune thyroiditis presenting with left intracranial hemorrhage after messenger RNA-1273 vaccination"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4408-1784","authenticated-orcid":false,"given":"Yi-Hsin","family":"Lin","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Taiwan Adventist Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Pediatric Surgery, Department of Surgery, Mackay Memorial Hospital, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Zern","family":"Hwang","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Department of Surgery, Taiwan Adventist Hospital, Taipei, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMe2002387","article-title":"Covid-19 - navigating the uncharted","volume":"382","author":"Fauci","year":"2020","journal-title":"N Engl J Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(20)31252-6","article-title":"COVID-19 vaccine development pipeline gears up","volume":"395","author":"Mullard","year":"2020","journal-title":"Lancet"},{"key":"R3-20250504","article-title":"Epidemic trend of COVID-19 in Taiwan, May to June 2021","author":"Lee","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","article-title":"Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine","volume":"385","author":"Falsey","year":"2021","journal-title":"N Engl J Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott","year":"2009","journal-title":"N Engl J Med"},{"key":"R7-20250504","first-page":"37","article-title":"Hypoplasia of the bilateral internal carotid arteries","volume":"9","author":"Takeuchi","year":"1957","journal-title":"Brain Nerve"},{"key":"R8-20250504","first-page":"49","article-title":"Moyamoya disease and syndromes: from genetics to clinical management","volume":"8","author":"Guey","year":"2015","journal-title":"Appl Clin Genet"},{"key":"R9-20250504","first-page":"1977","article-title":"Epidemiology, diagnosis and treatment of moyamoya disease","volume":"17","author":"Zhang","year":"2019","journal-title":"Exp Ther Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.3390\/jcm10163628","article-title":"Clinical management of moyamoya patients","volume":"10","author":"Canavero","year":"2021","journal-title":"J Clin Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/jhg.2010.132","article-title":"A genome-wide association study identifies RNF213 as the first Moyamoya disease gene","volume":"56","author":"Kamada","year":"2011","journal-title":"J Hum Genet"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1212\/WNL.0000000000008901","article-title":"Predictive role of heterozygous p.R4810K of RNF213 in the phenotype of Chinese moyamoya disease","volume":"94","author":"Wang","year":"2020","journal-title":"Neurology"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1086\/302243","article-title":"Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26","volume":"64","author":"Ikeda","year":"1999","journal-title":"Am J Hum Genet"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/088307380001500307","article-title":"Linkage analysis of moyamoya disease on chromosome 6","volume":"15","author":"Inoue","year":"2000","journal-title":"J Child Neurol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s10038-004-0143-6","article-title":"A novel susceptibility locus for moyamoya disease on chromosome 8q23","volume":"49","author":"Sakurai","year":"2004","journal-title":"J Hum Genet"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/STROKEAHA.111.000307","article-title":"Moyamoya disease in a primarily white, midwestern US population: increased prevalence of autoimmune disease","volume":"44","author":"Bower","year":"2013","journal-title":"Stroke"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3109\/03009749709065707","article-title":"SLE and Sj\u00f6gren's syndrome associated with unilateral moyamoya vessels in cerebral arteries","volume":"26","author":"Matsuki","year":"1997","journal-title":"Scand J Rheumatol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0961203313485828","article-title":"Systemic lupus erythematosus associated with Moyamoya syndrome: a case report and literature review","volume":"22","author":"Wang","year":"2013","journal-title":"Lupus"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"e36386","DOI":"10.1371\/journal.pone.0036386","article-title":"Clinical and immunopathological features of Moyamoya disease","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2176\/nmc.oa.2017-0198","article-title":"Association of hyperthyroidism and thyroid autoantibodies with moyamoya disease and its stroke event: a population-based case-control study and meta-analysis","volume":"58","author":"Ahn","year":"2018","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s12883-020-01923-w","article-title":"Intracranial arterial stenosis associated with Hashimoto's disease: angiographic features and clinical outcomes","volume":"20","author":"Hamano","year":"2020","journal-title":"BMC Neurol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"e002146","DOI":"10.1161\/JAHA.115.002146","article-title":"Biochemical and functional characterization of RNF213 (Mysterin) R4810K, a susceptibility mutation of moyamoya disease, in angiogenesis in vitro and in vivo","volume":"4","author":"Kobayashi","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"9991008","DOI":"10.1177\/1747493016662039","article-title":"Caveolin-1, ring finger protein 213, and endothelial function in moyamoya disease","volume":"11","author":"Bang","year":"2016","journal-title":"Int J Stroke"},{"issue":"(Suppl 2)","key":"R24-20250504","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0303-8467(97)00036-X","article-title":"Epidemiological study of moyamoya disease in Taiwan","volume":"99","author":"Hung","year":"1997","journal-title":"Clin Neurol Neurosurg"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1017\/cjn.2020.117","article-title":"COVID-19 presenting with thalamic hemorrhage unmasking moyamoya angiopathy","volume":"47","author":"Ghosh","year":"2020","journal-title":"Can J Neurol Sci"},{"key":"R26-20250504","first-page":"e60","article-title":"American College of Rheumatology Guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 3","volume":"73","author":"Curtis","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.chest.2021.01.080","article-title":"Should antipyretics be used to relieve acute adverse events related to COVID-19 vaccines?","volume":"159","author":"Etminan","year":"2021","journal-title":"Chest"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:02:45Z","timestamp":1746331365000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028756"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028756","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,2,11]]},"assertion":[{"value":"2021-11-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}